KBC Group’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
KBC Group's PGEN Position: Q3 2026 in Review
KBC Group increased its Precigen (PGEN) stake by 3.2% in Q3 2026, buying an estimated $71.9K and bringing the position to 356,759 shares worth $3.05M. The position accounts for 0.01% of the portfolio, ranked #589.
KBC Group first reported a position in PGEN in Q1 2026 and has held it in 3 quarters since. 191 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.
- KBC Group held 356,759 shares of Precigen worth $3.05M as of Q3 2026.
- KBC Group bought 10,954 Precigen shares in Q3 2026, an estimated $71.9K.
- Precigen made up 0.01% of KBC Group's portfolio in Q3 2026, its #589 holding.
- KBC Group first reported a position in Precigen in Q1 2026 and has held it in 3 quarters since.
- 191 funds tracked by Wall St. Rank held Precigen as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.